An mRNA influenza vaccine bests an inactivated quadrivalent flu vaccine against two different strains in phase 3 study.

A Stanford Medicine study suggests that the shingles vaccine reduces dementia risk by 20% in older adults, offering first ...

In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has ...

In a French cohort, the incidence of all-cause mortality among those who received a first dose of an mRNA COVID vaccine was 0 ...

The shingles vaccine not only offers protection against the painful viral infection, but a new study suggests that the two-dose shot also may slow the progression of dementia.

A study by Epi-Phare published on Thursday addresses misinformation surrounding vaccines that have been widely distributed ...

Americans are more likely to accept guidance on vaccines from the American Medical Association (AMA) than from the Centers ...